Kristen M. Kokkonen-Simon

发表

Marked disparity of microRNA modulation by cGMP-selective PDE5 versus PDE9 inhibitors in heart disease.

Dong Ik Lee, Marc K. Halushka, David A. Kass, 2018, JCI insight.

PKG-Modified TSC2 Regulates mTORC1 Activity to Counter Adverse Cardiac Stress

Dong Ik Lee, David A. Kass, Jennifer E. Van Eyk, 2018, Nature.

Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis

D. Kass, E. Olson, L. Liao, 2018, Nature Communications.

PKG1α Cysteine-42 Redox State Controls mTORC1 Activation in Pathological Cardiac Hypertrophy

Dong I. Lee, D. Kass, D. Bedja, 2020, Circulation research.

Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis–Associated Versus Idiopathic Pulmonary Arterial Hypertension

Ami A. Shah, D. Kass, M. Halushka, 2018, Circulation.

Prevention of PKG-1&agr; Oxidation Suppresses Antihypertrophic/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation

D. Kass, K. Tsujita, Grace E. Kim, 2018, Circulation. Heart failure.

CHIP phosphorylation by protein kinase G enhances protein quality control and attenuates cardiac ischemic injury

Dong I. Lee, D. Kass, V. Agrawal, 2020, Nature Communications.

PKG-Modified TSC2 Regulates mTORC1 Activity to Counter Adverse Cardiac Stress

Dong I. Lee, D. Kass, J. V. Van Eyk, 2018, Nature.